SATURDAY, SEPTEMBER 24, 2016

IAVI affirms NIAID statements on importance, challenge of AIDS vaccine

The International AIDS Vaccine Initiative released a statement on Friday in response to National Institute of Allergy and Infectious Diseases studies that said the end of the AIDS pandemic will come with time and dedicated work.

Anthony S. Fauci and his colleagues released the studies, which were published in The Lancet, Cell and Nature Immunology and said effective vaccines are the key to ending the AIDS pandemic. The studies also named the challenges to reaching this goal and potential solutions.

"As Dr. Fauci has repeatedly stressed, the essential quest for an AIDS vaccine is a marathon, not a sprint, and it requires sustained time, talent and resources," IAVI President and Chief Executive Officer Margaret McGlynn said.

IAVI said that as research increases about the HIV virus, new solutions to fighting the pandemic show themselves. Plans for a vector prime and protein boost concept and the development of a broad-range neutralizing antibody show promise.

"We are learning more and more about the evolution of HIV by geography and in the body; the responding maturation of broadly neutralizing antibodies, and the structure of the HIV envelope protein which these antibodies must target," IAVI Chief Scientific Officer Wayne Koff said. "These insights will help us develop future vaccine candidates that can induce antibodies to protect broadly from HIV infection."

IAVI said it looks forward to continuing to discover effective vaccine candidates against HIV and AIDS with the help of partners to bring an end to the AIDS pandemic once and for all.